Category: M&A

A.M. Vitals: Malaria Studies in Mice Raise Hopes of New Treatment

MEwens
Also: Stem cell legislation in the House; Abbott ends an auction; NYC public hospitals prepare for some changes.
Read more this great post here

Continued Read ...

A.M. Vitals: Genzyme Points to MS Drug As Sign Sanofi Bid is Too Low

Laura Landro
Also: Most C-sections performed before labor starts; American companies push into Chinese electronic medical record market; investigators looking at health-care credit cards.
Read more this great post here

Continued Read ...
Posted in Drugs, M&A, IT, China, Mulitple Sclerosis  

Public Hospitals, ‘Poorly Equipped to Survive,’ Are Being Sold

MEwens
Public hospitals are being sold amidst a general boom in hospital M&A activity.
Read more this great post here

Continued Read ...
Posted in Hospitals, M&A  

A.M. Vitals: Genzyme Rejects Takeover Offer From Sanofi-Aventis

Katherine Hobson
Also: 50 million Americans on Medicaid; two studies boost Plavix rivals; pediatricians say no erectile dysfunction drug ads before 10pm.
Read more this great post here

Continued Read ...

A.M. Vitals: Judge Blocks Federal Funding of Embryonic Stem Cell Research

Katherine Hobson
Also: study quantifies radiation from nuclear imaging tests; Genzyme and Sanofi talk price; routine care coverage for clinical trial participants.
Read more this great post here

Continued Read ...

Hail Mary Pass? Group Asks Pope to Block Hospital Sale to Cerberus

MEwens
Will the Pope sign off on a private-equity deal?
Read more this great post here

Continued Read ...
Posted in Hospitals, M&A, Ethics  

A.M. Vitals: Pharma Companies Tapping Early-Stage Biotech Products

Katherine Hobson
Also: NJ suit on involuntary medication; FDA wants to clarify device-approval process; Consumer Reports identifies supplement ingredients with scary side effects.
Read more this great post here

Continued Read ...
Posted in Biotech, M&A, Consumer health, Legal  

Genzyme and Pfizer, Kissin’ in a Tree? Probably Not.

Katherine Hobson
Pfizer CFO said on an earnings call with analysts that his company is looking for acquisitions worth between a few billion to several billion dollars.
Read more this great post here

Continued Read ...
Posted in M&A, Pfizer  

Merck Ready to Play Let’s Make an (Emerging Markets) Deal

MEwens
Merck isn’t ruling out making outright purchases of emerging-market companies, but competition is fierce.
Read more this great post here

Continued Read ...
Posted in Drugs, Global, M&A, China  

A.M. Vitals: Sanofi Likely to Formally Offer to Buy Genzyme

Katherine Hobson
Also: new painkiller policy proposed in Washington State; the insured seem to be using less health care; Dendreon publishes results in the NEJM.
Read more this great post here

Continued Read ...

Next Page »